0.495
Osr Holdings Inc Aktie (OSRH) Neueste Nachrichten
OSR appoints Andreas Niethammer as Chief Medical Officer of Vaximm AG - MSN
OSR Holdings Q4 2025 Earnings: EPS Misses Estimates Amidst Weak Market SentimentEBITDA Margin Trends - Newser
OSR Holdings (OSRH) Q4 2025 Earnings: Miss Sparks ConcernDownward Estimate Revision - Newser
OSR Holdings (OSRH) Falls -1.94% — Watching $0.47 Support 2026-05-20Straddle Setup - Newser
Should You Sell OSR Holdings (OSRH) After -8.25% Drop? 2026-05-18High Interest Stocks - Newser
OSR Holdings stock surges over 41% after hours: Why is it moving? - MSN
OSRH - Finviz
Number of shareholders of OSR Holdings, Inc. – NASDAQ:OSRH - TradingView
TradingKey - TradingKey
OSR Holdings, Inc. Q1 2026 Financial Report: Business Combination, Subsidiary Overview, and Key Financial Results - Minichart
OSR Holdings, Inc. 1Q 2026: Revenue $484.1K, EPS $(0.08) — 10-Q Summary - TradingView
OSR Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] OSR Holdings, Inc. Quarterly Earnings Report - Stock Titan
OSR Holdings rules out reverse stock split amid Nasdaq compliance efforts - Investing.com
CEO Statement to Shareholders - marketscreener.com
About Us | Cabling Installation & MaintenanceCEO Statement to Shareholders - FinancialContent
OSR Holdings (OSRH) seeks approval to raise equity plan to 8.0M shares, name change - Stock Titan
How OSR Holdings (OSRH) geographic mix shifted this quarter | Q4 2025: EPS Misses EstimatesSocial Buzz Stocks - newser.com
Why OSR (OSRHW) ability to generate cash matters (Soars) 2026-05-08Growth Factor - Newser
OSR Holdings–BCM Europe VXM01 Global License Deal: Avance Fairness Opinion Confirms Financial Terms Are Fair for Shareholders - Minichart
The edge OSR (OSRHW) has in a competitive landscape (Skyrockets) 2026-05-06Trending Stock Ideas - newser.com
OSR Holdings (NASDAQ: OSRH) gets fairness view on $815M VXM01 deal - Stock Titan
Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target - Scott Coop
OSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stock - MSN
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 - Black Hills Pioneer
OSRH Stock Price, Quote & Chart | OSR HOLDINGS INC (NASDAQ:OSRH) - ChartMill
OSRH Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock - Stocktwits
These stocks are moving in today's session - ChartMill
Check out the stocks that are attracting the most attention and driving market activity. - ChartMill
OSR Holdings Grants BCME Exclusive Global VXM01 Rights - TipRanks
BCM Europe pledges 29.7% OSR Holdings (NASDAQ: OSRH) stake in $815M VXM01 deal - Stock Titan
OSR Holdings to explain its VXM01 licensing deal in May 7 webcast - Stock Titan
OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?OSR Holdings (NASDAQ:OSRH) - Benzinga
OSR Holdings (OSRH) Stock: Direction Change Signals | Q4 2025: Earnings Fall ShortFloat Short - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What's going on in today's after hours session - ChartMill
Wednesday's session: top gainers and losers - ChartMill
OSR Holdings licenses VXM01 to BCME for up to $815M in milestones By Investing.com - Investing.com South Africa
OSR Holdings licenses VXM01 to BCME for up to $815M in milestones - Investing.com Australia
OSR Holdings Announces $815M License Agreement for VXM01 - ACCESS Newswire
OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe - newswire.com
Top shareholder pledges 29.7% stake behind OSR Holdings' $815M drug deal - Stock Titan
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target - The Florida Times-Union
OSR Holdings Appoints Yeiseok Kim as Chief Operating Officer Effective April 16, 2026 7 - Minichart
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):